Results 111 to 120 of about 15,040 (247)

How Postmortem Redistribution of MDMA in Acute Alcohol-MDMA Combined-Use Rats Change under Effects of Alcohol

Scientific Reports, 2017
MDMA is often taken recreationally with alcohol as combined-use. The objective was to determine MDMA postmortem redistribution (PMR) and corresponding effects in combined-style under different storage conditions.
Man Liang, Jing Zhang, Na Zheng, Liang Liu   +3 more
doaj   +1 more source

Measuring effects of MDMA (ecstasy) abuse on the rate of cerebral serotonin synthesis

, 2014
The article by Professor Booij et al. (2014) appearing in this issue raises a number of interesting questions related to the neurotoxic effects of recreational MDMA (ecstasy) use.
Cumming, Paul
core   +1 more source

Prospective memory deficits in illicit polydrug users are associated with the average long term typical dose of ecstasy typically consumed in a single session [PDF]

, 2014
Rationale Neuroimaging evidence suggests that ecstasy-related reductions in SERT densities relate more closely to the number of tablets typically consumed per session rather than estimated total lifetime use.
Montgomery, C, Fisk, John E., Robinson, Sarita J., Hadjiefthyvoulou, F, Robinson, SJ, Gallagher, Denis Thomas, Gallagher, Denis T., Judge, Jeannie, Judge, J, Robinson, Sarita Jane, Gallagher, DT, Fisk, John, Montgomery, Catharine, Fisk, JE, Hadjiefthyvoulou, Florentia   +14 more
core   +1 more source

Innovative Nanomaterial‐Based Approaches for the Recognition of Amphetamine in Attention Deficit Hyperactivity Disorder Management

Analytical Science Advances, Volume 7, Issue 1, June 2026.
ABSTRACT The rising incidence of amphetamine misuse, particularly in the context of attention deficit hyperactivity disorder treatment, underscores the urgent need for sensitive and effective detection methods. This review examines innovative nanomaterial‐based approaches for AMP detection, emphasizing their advantages over conventional analytical ...
Ilghar Zeinaly, Ghazal Koohkansaadi, Majid Hassanzadeh‐Khanmiri, Ahmad Mobed, Saeid Charsouei, Arash Mohagheghi   +5 more
wiley   +1 more source

Mean (SD) MDMA/MDA concentrations (µg/L) in MDMA and the combined pindolol+MDMA condition.

, 2014
Mean (SD) MDMA/MDA concentrations (µg/L) in MDMA and the combined pindolol+MDMA condition.
Rafael de la Torre (125317), Isabel Dziobek (418517), Samanta Yubero-Lahoz (125301), Kim P. C. Kuypers (290936), Magi Farre (5659783), Wouter Van den Bos (5659786), Johannes G. Ramaekers (290937)   +6 more
core   +1 more source

Preliminary evidence for the importance of therapeutic alliance in MDMA-assisted psychotherapy for posttraumatic stress disorder

European Journal of Psychotraumatology
Background: MDMA-assisted psychotherapy (MDMA-AP) is a combined psychotherapeutic and pharmacologic intervention that shows promise in the treatment of posttraumatic stress disorder (PTSD).
Richard J. Zeifman, Hannes Kettner, Stephen Ross, Brandon Weiss, Michael C. Mithoefer, Ann T. Mithoefer, Anne C. Wagner   +6 more
doaj   +1 more source

Clinical pharmacology and prescribing education: An updated medical school curriculum from the British Pharmacological Society

British Journal of Clinical Pharmacology, Volume 92, Issue 6, Page 1787-1808, June 2026.
Aims Prescribing is a complex, essential skill that doctors must acquire to practice medicine safely and effectively. The British Pharmacological Society has historically provided a core curriculum to guide clinical pharmacology and prescribing education in UK medical schools.
Dagan O. Lonsdale, Clare Guilding, Jennifer Koenig, Michael Okorie, Reecha Sofat, Simon Maxwell   +5 more
wiley   +1 more source

A Missing Voice? Peer Support Workers’ Perceptions of Psychedelic‐Assisted Therapy in Australia: A Cross‐Sectional Survey

Brain and Behavior, Volume 16, Issue 6, June 2026.
Despite their capacity to bridge providers and clients, peer support workers remain largely absent from Australia's emerging psychedelic‐assisted therapy (PAT) landscape. This study identifies a broadly supportive and optimistic PSW workforce, while highlighting the need for tailored education pathways and structured integration models to enable ...
Aloysius Amos Lau, Shalini Arunogiri, Boen Raner‐Galutera, Siegfried Lichtwark, Sarah J. Catchlove   +4 more
wiley   +1 more source

Duloxetine increased MDMA exposure.

, 2012
Pharmacokinetics of MDMA, MDA, HMMA, and duloxetine (a–d). Duloxetine was administered 16 h and 4 h before MDMA, which was administered at the 0 h time point. Duloxetine increased the Cmax and AUC0–6 of MDMA (a), had no significant effect on MDA exposure
Marius C. Hoener (166578), Cédric M. Hysek (166535), Linda D. Simmler (166540), Massimiliano Donzelli (166552), Valentina G. Nicola (166543), Stephan Krähenbühl (166557), Nerina Vischer (166548), Jörg Huwyler (166572), Eric Grouzmann (166564), Matthias E. Liechti (166584)   +9 more
core   +1 more source

Expectations and Motivations for Participation in Clinical Trials Utilizing Psychedelics for Treatment‐Resistant Depression: A Qualitative Study

Brain and Behavior, Volume 16, Issue 6, June 2026.
Individuals with treatment‐resistant depression considering psychedelic trial participation were motivated by chronic illness, failed treatments, and hope for a novel intervention, while actively minimizing expectations to guard against disappointment.
Christopher Poppe, Liisa Lyck, Laura Bechtold, Dimitris Repantis   +3 more
wiley   +1 more source